Intellectus Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,942
| Closed | -$357K | – | 282 |
|
|
2021
Q2 | $357K | Sell |
1,942
-342
| -15% | -$62.9K | 0.08% | 217 |
|
|
2021
Q1 | $349K | Sell |
2,284
-251
| -10% | -$38.4K | 0.1% | 205 |
|
|
2020
Q4 | $396K | Sell |
2,535
-823
| -25% | -$129K | 0.12% | 177 |
|
|
2020
Q3 | $384K | Buy |
3,358
+823
| +32% | +$94.1K | 0.15% | 160 |
|
|
2020
Q2 | $285K | Hold |
2,535
| – | – | 0.11% | 177 |
|
|
2020
Q1 | $228K | Buy |
+2,535
| New | +$228K | 0.11% | 174 |
|
|
2017
Q3 | – | Sell |
-36
| Closed | -$14K | – | 789 |
|
|
2017
Q2 | $14K | Buy |
+36
| New | +$14K | 0.01% | 549 |
|